http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004166129-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0662
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
filingDate 2003-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f275c04beef72c4d3da98beb080921f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c22cb1d9f12b6dc37b9045d6344161ab
publicationDate 2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004166129-A1
titleOfInvention Illumination radiation treatment of skin conditions
abstract A method and apparatus for the cosmetic treatment of a skin condition (particularly Acne Vulgaris). Illuminating radiation (including radiation of a predetermined wavelength) is directed toward a target zone in accordance with a predetermined delivery regime. A plurality of interactions are effected at the target zone including a reaction leading to at least partial disabling or eradication of the cause of the skin condition, and non-ablative heating of tissue stimulating an inflammatory response to a degree sufficient to effect collagen production. The two-fold interaction system effected by the illuminating radiation provides an extremely effective cosmetic effect.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010056982-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005055070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8980174-B2
priorityDate 2000-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6214034-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5885274-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6183500-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6645230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6269818-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6835202-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5968034-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481287
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID84883
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID84883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396789
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128590101

Total number of triples: 38.